The group’s principle activity is to provide surgical platform technology for minimally invasive biopsy and tissue removal. The group also designs intervention solutions for accurate diagnosis and effective treatment of abnormalities. The group’s technology includes Automated Tissue Excision and Collection technology. TThe group operates from United States.
